• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂质-聚合物杂化纳米颗粒的 siRNA 递药动力学的机制分析。

Mechanistic profiling of the siRNA delivery dynamics of lipid-polymer hybrid nanoparticles.

机构信息

Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, 2100 Copenhagen O, Denmark.

Department of Pharmaceutical Sciences, Shenyang Pharmaceutical University, Shenyang, Wenhua Road 103, 110016, China.

出版信息

J Control Release. 2015 Mar 10;201:22-31. doi: 10.1016/j.jconrel.2014.12.026. Epub 2014 Dec 23.

DOI:10.1016/j.jconrel.2014.12.026
PMID:25540904
Abstract

Understanding the delivery dynamics of nucleic acid nanocarriers is fundamental to improve their design for therapeutic applications. We investigated the carrier structure-function relationship of lipid-polymer hybrid nanoparticles (LPNs) consisting of poly(DL-lactic-co-glycolic acid) (PLGA) nanocarriers modified with the cationic lipid dioleoyltrimethyl-ammoniumpropane (DOTAP). A library of siRNA-loaded LPNs was prepared by systematically varying the nitrogen-to-phosphate (N/P) ratio. Atomic force microscopy (AFM) and cryo-transmission electron microscopy (cryo-TEM) combined with small angle X-ray scattering (SAXS) and confocal laser scanning microscopy (CLSM) studies suggested that the siRNA-loaded LPNs are characterized by a core-shell structure consisting of a PLGA matrix core coated with lamellar DOTAP structures with siRNA localized both in the core and in the shell. Release studies in buffer and serum-containing medium combined with in vitro gene silencing and quantification of intracellular siRNA suggested that this self-assembling core-shell structure influences the siRNA release kinetics and the delivery dynamics. A main delivery mechanism appears to be mediated via the release of transfection-competent siRNA-DOTAP lipoplexes from the LPNs. Based on these results, we suggest a model for the nanostructural characteristics of the LPNs, in which the siRNA is organized in lamellar superficial assemblies and/or as complexes entrapped in the polymeric matrix.

摘要

了解核酸纳米载体的递药动力学对于改进其治疗应用的设计至关重要。我们研究了由聚(DL-丙交酯-共-乙交酯)(PLGA)纳米载体和阳离子脂质二油酰基三甲基-丙铵(DOTAP)修饰而成的脂-聚混合纳米粒子(LPN)的载体结构-功能关系。通过系统改变氮-磷(N/P)比制备了载有 siRNA 的 LPN 文库。原子力显微镜(AFM)和冷冻透射电子显微镜(cryo-TEM)结合小角 X 射线散射(SAXS)和共聚焦激光扫描显微镜(CLSM)研究表明,siRNA 负载的 LPN 具有由 PLGA 基质核心组成的核壳结构,该核心涂有层状 DOTAP 结构,siRNA 定位于核心和壳层中。在缓冲液和含血清的培养基中的释放研究,以及体外基因沉默和细胞内 siRNA 的定量,表明这种自组装的核壳结构会影响 siRNA 的释放动力学和递药动力学。一种主要的递药机制似乎是通过从 LPN 中释放具有转染能力的 siRNA-DOTAP 脂质体复合物来介导的。基于这些结果,我们提出了 LPN 的纳米结构特征模型,其中 siRNA 以层状表面组装的形式存在和/或作为复合物被包埋在聚合物基质中。

相似文献

1
Mechanistic profiling of the siRNA delivery dynamics of lipid-polymer hybrid nanoparticles.脂质-聚合物杂化纳米颗粒的 siRNA 递药动力学的机制分析。
J Control Release. 2015 Mar 10;201:22-31. doi: 10.1016/j.jconrel.2014.12.026. Epub 2014 Dec 23.
2
Engineering of small interfering RNA-loaded lipidoid-poly(DL-lactic-co-glycolic acid) hybrid nanoparticles for highly efficient and safe gene silencing: A quality by design-based approach.载小分子干扰 RNA 的脂质体-聚(DL-乳酸-共-乙醇酸)杂化纳米粒的工程化:基于质量源于设计的方法用于高效和安全的基因沉默。
Eur J Pharm Biopharm. 2017 Nov;120:22-33. doi: 10.1016/j.ejpb.2017.07.014. Epub 2017 Jul 26.
3
Mechanistic profiling of the release kinetics of siRNA from lipidoid-polymer hybrid nanoparticles in vitro and in vivo after pulmonary administration.经肺部给药后,体外和体内脂质体-聚合物杂化纳米粒中 siRNA 释放动力学的机制分析。
J Control Release. 2019 Sep 28;310:82-93. doi: 10.1016/j.jconrel.2019.08.004. Epub 2019 Aug 6.
4
Design of an inhalable dry powder formulation of DOTAP-modified PLGA nanoparticles loaded with siRNA.设计一种载有 siRNA 的 DOTAP 修饰的 PLGA 纳米粒干粉吸入制剂。
J Control Release. 2012 Jan 10;157(1):141-8. doi: 10.1016/j.jconrel.2011.08.011. Epub 2011 Aug 12.
5
Poly(lactide--glycolide) Nanoparticles Mediate Sustained Gene Silencing and Improved Biocompatibility of siRNA Delivery Systems in Mouse Lungs after Pulmonary Administration.聚(丙交酯-乙交酯)纳米颗粒介导的持续基因沉默,并改善了肺部给药后小鼠肺部 siRNA 递药系统的生物相容性。
ACS Appl Mater Interfaces. 2021 Jan 27;13(3):3722-3737. doi: 10.1021/acsami.0c21259. Epub 2021 Jan 13.
6
Elucidating the nanostructure of small interfering RNA-loaded lipidoid-polymer hybrid nanoparticles.解析负载小干扰RNA的类脂质-聚合物杂化纳米颗粒的纳米结构
J Colloid Interface Sci. 2023 Mar;633:907-922. doi: 10.1016/j.jcis.2022.11.141. Epub 2022 Nov 28.
7
Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.脂质-聚合物杂化纳米颗粒作为新一代治疗性递送平台:综述
Eur J Pharm Biopharm. 2013 Nov;85(3 Pt A):427-43. doi: 10.1016/j.ejpb.2013.07.002. Epub 2013 Jul 17.
8
Polymeric nanoparticles for siRNA delivery and gene silencing.用于siRNA递送和基因沉默的聚合物纳米颗粒。
Int J Pharm. 2009 Feb 9;367(1-2):195-203. doi: 10.1016/j.ijpharm.2008.09.039. Epub 2008 Oct 1.
9
Engineering of budesonide-loaded lipid-polymer hybrid nanoparticles using a quality-by-design approach.采用质量源于设计方法工程化负载布地奈德的脂质-聚合物杂化纳米粒。
Int J Pharm. 2018 Sep 15;548(2):740-746. doi: 10.1016/j.ijpharm.2017.08.094. Epub 2017 Aug 25.
10
Lipidoid-polymer hybrid nanoparticles loaded with TNF siRNA suppress inflammation after intra-articular administration in a murine experimental arthritis model.载 TNF siRNA 的脂质体-聚合物杂化纳米颗粒经关节内给药后可抑制小鼠实验性关节炎模型中的炎症反应。
Eur J Pharm Biopharm. 2019 Sep;142:38-48. doi: 10.1016/j.ejpb.2019.06.009. Epub 2019 Jun 11.

引用本文的文献

1
Advancements in gene therapies targeting mutant KRAS in cancers.针对癌症中突变型KRAS的基因疗法进展。
Cancer Metastasis Rev. 2025 Jan 17;44(1):24. doi: 10.1007/s10555-025-10243-9.
2
Development and Evaluation of Docetaxel-Loaded Nanostructured Lipid Carriers for Skin Cancer Therapy.用于皮肤癌治疗的多西他赛纳米结构脂质载体的研发与评价
Pharmaceutics. 2024 Jul 19;16(7):960. doi: 10.3390/pharmaceutics16070960.
3
State-of-the-Art Review on Inhalable Lipid and Polymer Nanocarriers: Design and Development Perspectives.吸入性脂质和聚合物纳米载体的最新综述:设计与开发展望
Pharmaceutics. 2024 Mar 1;16(3):347. doi: 10.3390/pharmaceutics16030347.
4
Tools shaping drug discovery and development.塑造药物发现与开发的工具。
Biophys Rev (Melville). 2022 Jul 27;3(3):031301. doi: 10.1063/5.0087583. eCollection 2022 Sep.
5
Delivery of RNA to the Blood-Brain Barrier Endothelium Using Cationic Bicelles.使用阳离子双分子层将RNA递送至血脑屏障内皮细胞。
Pharmaceutics. 2023 Aug 4;15(8):2086. doi: 10.3390/pharmaceutics15082086.
6
siRNA-based nanotherapeutics as emerging modalities for immune-mediated diseases: A preliminary review.基于 siRNA 的纳米治疗学作为免疫介导性疾病的新兴治疗模式:初步综述。
Cell Biol Int. 2022 Sep;46(9):1320-1344. doi: 10.1002/cbin.11841. Epub 2022 Jul 13.
7
mRNA-Based Cancer Vaccines: A Therapeutic Strategy for the Treatment of Melanoma Patients.基于信使核糖核酸的癌症疫苗:一种治疗黑色素瘤患者的治疗策略。
Vaccines (Basel). 2021 Sep 23;9(10):1060. doi: 10.3390/vaccines9101060.
8
Modulation of Colorectal Tumor Behavior via lncRNA TP53TG1-Lipidic Nanosystem.通过lncRNA TP53TG1-脂质纳米系统调控结直肠癌行为
Pharmaceutics. 2021 Sep 18;13(9):1507. doi: 10.3390/pharmaceutics13091507.
9
Engineering of Solid Dosage Forms of siRNA-Loaded Lipidoid-Polymer Hybrid Nanoparticles Using a Quality-by-Design Approach.采用质量源于设计方法工程化载 siRNA 的脂质体-聚合物杂化纳米粒的固体剂型。
Methods Mol Biol. 2021;2282:137-157. doi: 10.1007/978-1-0716-1298-9_9.
10
Optimizing the Intracellular Delivery of Therapeutic Anti-inflammatory TNF-α siRNA to Activated Macrophages Using Lipidoid-Polymer Hybrid Nanoparticles.使用类脂质-聚合物杂化纳米颗粒优化治疗性抗炎TNF-α siRNA向活化巨噬细胞的细胞内递送
Front Bioeng Biotechnol. 2021 Jan 14;8:601155. doi: 10.3389/fbioe.2020.601155. eCollection 2020.